This is a preview of subscription content, access via your institution.

References
Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH (1979) An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38(5):434–439
Dasgupta B, Cimmino MA, Maradit-Kremers H et al (2012) provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71(4):484–492
Jacob A, Unnikrishnan DC, Mathew A, Thyagarajan B, Patel S (2016) A case of fatal Guillain–Barre syndrome from anti-PD1 monoclonal antibody use. J Cancer Res Clin Oncol 142(8):1869–1870
Kimura T, Fukushima S, Miyashita A et al (2016) Myasthenic crisis and polymyositis induced by one dose of nivolumab. Cancer Sci 107(7):1055–1058
Larkin J, Hodi FS, Wolchok JD (2015) Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 373(13):1270–1271
Wang C, Thudium KB, Han M et al (2014) In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol Res 2(9):846–856
Acknowledgements
This work was supported by JSPS KAKENHI Grant number JP 26460901.
Author information
Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflicts of interests.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from an individual participant included in the case.
Rights and permissions
About this article
Cite this article
Nakamagoe, K., Moriyama, T., Maruyama, H. et al. Polymyalgia rheumatica in a melanoma patient due to nivolumab treatment. J Cancer Res Clin Oncol 143, 1357–1358 (2017). https://doi.org/10.1007/s00432-017-2410-x
Received:
Accepted:
Published:
Issue Date:
Keywords
- Bursitis
- Biceps Brachii
- Morning Stiffness
- Tenosynovitis
- Polymyalgia Rheumatica